Rodríguez MF

Language: Spanish
References: 16
Page: 339-342
PDF size: 167.74 Kb.

ABSTRACT

Gastric cancer is one of the main causes of mortality due to cancer in the world, and despite the fact that its incidence has been in declining over the years, it still remains as the most frequent cancer in developing countries. The most frequent type of cancer is called adenocarcinoma (90 %), with a predominantly distal intestinal variant and other diffuse. Among the most recognized risk factors that have been associated we can find chronic atrophic gastritis with intestinal metaplasia, Helicobacter pylori infection, diets rich in salted, smoked or dried food, smoking, and pernicious anemia, amongst others.

REFERENCES

1. Bonney, G, Elston, RC, Correa, P, et al. 1986. Genetic association of gastric carcinoma: chronic atrophyc gastritis. Genet Epidemiol 3: 213- 224

2. Burkitt, MD, Viarro, A, Caamano, J, Pritchard, DM. Classical and alternative pathway nuclear factorkb signaling differentially regulate gastric epithelial responses to Helicobacter felis infection. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL. Mo 1901.

3. Capelle, L, Den Hoed, CM, van Grieken, NC, et al. Gastric cancer in Lynch syndrome patients: is surveillance justified? Sesión de carteles presentada en DDW 211; mayo 7-10; Chicago, IL. Sa 1227

4. Esteban, CE, Manrique, AI, Sastre, VJ, Díaz-Rubio, GE 2000. Cáncer de estómago. En: Díaz-Rubio, E, García-Conde, J. Oncología Clínica Básica (Arán Ediciones) pp 406-410

5. Fields, RC, Strong, VE, Gonen, M, et al. 2011. Patterns of recurrence and 342 REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA survival after complete pathologic response to neoadjuvant treatment for gastric and gastroesophageal junction adenocarcinoma. Ann Sung Oncol 18 [Suppl1): 69

6. Gonda, TA, Takaishi, S, Shibata, W, et al. The effect of folate supplementation on global methylation and progression of gastric cancer in transgenic hypergastrinemic murine model. Sesión de trabajos orales presentada en DDW 2011; mayo 7-10; Chicago, IL. #954

7. Kaise, M, Miwa, J, Tashiro, J, et al. Serum trefoil factor 3 is a valid nonendoscopic biomarker for predicting the presence of gastric cancer Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL.Sa 1877

8. Lauren P. 1965. The two histological main types of gastric cancer: diffuse and so called intestinal type carcinoma. An attempt at a histological classification. Acta Pathol Microbial Scand 64: 31-49

9. Lucio, L, Rocca, R, Chiecchio, A, et al. Decreasing prevalence of HP infection and incidence of gastric cancer in Northwest Italy. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL. Sa 1946

10. Lucio L, Rocca R, Chiecchio A, et al. Op. Cit.

11. Medina-Franco, Herberto 2011 Cáncer Gástrico. Revista de Gastroenterología de México Supl. 1(76): 88-91

12. Medina-Franco, Heriberto. Op. Cit.

13. Muñoz, NB 2002. Epidemiology of gastric cancer. In: Posner, MC, Vokes, EE, Weichselbaum. Cancer of the upper Gastrointestinal Tract. (BC Decker, Hamilton, London) pp 206-217

14. Murphy, GA, Kamangar, F, Dawsey, SM, et al. Low serum ghrelin is associated with an increased risk of gastric adenocarcinoma. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL. Sa 1919

15. Siripurapu, V, Zhu, F, Watson, C, et al. 2011. Use of perioperative therapy in gastric cancer; a retrospective comparison of ECF and chemoradiation. Ann Surg Oncol 18 (Suppl1): pp138

16. World Cancer Research Fundation. 1997. Food, nutrition and the prevention of cancer: a global perspective. Washington DC: World Cancer Research Fundation, American Institute for Cancer Research.